Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1819|72|1|45-46

ISSN： 1323-1316

Source： PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol.72, Iss.1, 2018-01, pp. : 45-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 27, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activity-related pain in patients with chronic musculoskeletal disorders

By Damsgard Elin   Thrane Gyrd   Anke Audny   FORS Terese   Røe Cecilie  

Disability and Rehabilitation, Vol. 32, Iss. 17, 2010-12 ,pp. : 1428-1437

Informa Healthcare

Access to resources Recommend Favorite

Chronic musculoskeletal pain

By Carnes Dawn   Underwood Martin  

British Journal of General Practice, Vol. 57, Iss. 541, 2007-08 ,pp. : 604-605

Royal College of General Practitioners

Access to resources Recommend Favorite

Influence of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients with Severe Thrombocytopenia after Chemotherapy: A Retrospective Study

By  

Acta Haematologica, Vol. 133, Iss. 3, 2014-12 ,pp. : 317-320

Karger

Access to resources Recommend Favorite

Preadmission use of selective serotonin reuptake inhibitors and short‐term mortality in diabetic patients hospitalized due to stroke

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 280, Iss. 4, 2016-10 ,pp. : 407-418

John Wiley & Sons Inc

Access to resources Recommend Favorite